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http:WHAT THIS PAPER ADDS
This article studies the association between abdominal aortic aneurysm (AAA) and coronary artery disease (CAD)
in a large contemporary series of patients undergoing coronary angiography. Although this association has been
described previously, this is the ﬁrst study that clearly correlates the frequency of AAA with the severity of CAD.
Despite the fact that some recent epidemiologic studies suggest a decrease in the prevalence of AAA in the
general population, we demonstrate that the disease remains widespread in the population of patients with
three-vessel CAD, and we recommend cardiologists be aware of this association.Objectives: Currently, the prevalence of abdominal aortic aneurysm (AAA) in patients with coronary artery
disease (CAD) and the correlation between CAD severity and AAA prevalence are not clearly known. We
conducted a prospective study to determine the prevalence of AAA in patients undergoing coronary angiography
and to determine the risk factors and a coronary proﬁle associated with AAA.
Methods: Over an 18-month period, abdominal aortic ultrasound was performed on 1,000 patients undergoing
coronary angiography for suspected or known CAD, or prior to valve surgery. Clinical characteristics and coronary
proﬁle were collected from the patients.
Results: The overall number of previously repaired, already diagnosed, and new cases of AAA in the study
population was 42, yielding a prevalence of 4.2%. Among the patients with newly detected AAAs, only two had
an AAA diameter of >54 mm and were therefore treated surgically. In men aged 65 years, the prevalence
reached 8.6%, while in men with three-vessel CAD it was 14.4%. Multivariate analysis showed that age 65 years
(p ¼ .003), male gender (p ¼ .003), family history of AAA (p ¼ .01), current smoking (p ¼ .002), and three-vessel
CAD (p < .001) were signiﬁcantly associated with a higher prevalence of AAA.
Conclusion: The prevalence of AAA was high in men aged 65 years and in those with three-vessel CAD
regardless of age. While our ﬁndings do not prove the cost-effectiveness of screening for AAA in these high risk
patients, they do support the usefulness of a quick ultrasound examination of the abdominal aorta during routine
transthoracic echocardiography in such patients.
 2013 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.
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Abdominal aortic aneurysm (AAA) is a chronic degenerative
disease and an important cause of preventable death in the
elderly. The overall mortality rate for patients with ruptured
AAA varies between 65% and 85%,1e3 and about half of the
deaths attributed to rupture occur before the patient rea-
ches the operating room. In contrast, the mortality rate for
an elective AAA repair ranges from 0.6% to 5.3%.4e7rresponding author. R. Durieux, Department of Cardiovascular and
ic Surgery, University Hospital of Liège, Sart Tilman, B35, 4000 Liège,
.
il address: rdurieux@chu.ulg.ac.be (R. Durieux).
-5884/$ e see front matter  2013 European Society for Vascular
. Published by Elsevier Ltd. All rights reserved.
//dx.doi.org/10.1016/j.ejvs.2013.12.011Several population-based studies have shown evident
beneﬁt in terms of mortality from screening for AAA among
men aged 65 years8e10 and the Multicentre Aneurysm
Screening Study11 has demonstrated that screening is also
cost-effective. In spite of this ﬁnding, few screening pro-
grams have been implemented in Europe, USA, and
Australia.
Epidemiologic screening studies have suggested an as-
sociation between AAA and atherosclerosis, such as coro-
nary artery (CAD) or peripheral arterial disease (PAD).12 The
current prevalence of AAA in patients with CAD is not well
known, although the prevalence of AAA in patients under-
going a coronary artery bypass graft or with acute coronary
syndrome has been reported to be higher than in the
general population, ranging from 6.6% to 18.2%.13e18 In
274 R. Durieux et al.contrast, several recent studies have indicated a decrease in
the prevalence of AAA in the general population.19e21
The objective of the present study was to determine the
prevalence of AAA in patients undergoing coronary angi-
ography and to elucidate the risk factors and the coronary
proﬁle associated with AAA. Our goal was to provide evi-
dence for a more targeted AAA screening strategy in
selected groups of patients with an elevated risk of AAA
development.MATERIAL AND METHODS
Study design
Between March 2009 and August 2010, a prospective study
was conducted in the departments of cardiology and car-
diovascular surgery of the University Hospital of Liège,
Belgium. All patients undergoing coronary angiography
prior to valve surgery or for suspected or known CAD were
eligible for inclusion in the study. Patients with known AAA
or with a previous replacement of the abdominal aorta for
aneurysmal disease were also included. The clinical char-
acteristics of the patients and their coronary proﬁle were
prospectively collected (see Supplementary Methods). The
study was approved by the Ethics Committee of the Uni-
versity Hospital, and patients were asked to provide
informed consent.Patient selection
1,027 consecutive patients were invited for an ultrasound
(US) screening during the 18-month study period. Of these
patients, 21 (2.0%) refused to participate and in six other
patients, the abdominal aorta could not be properly visu-
alized because of abdominal obesity. Thus, a total of 1,000
patients (699 men and 301 women) were involved in the US
screening program. All patients were of European ancestry.
Their characteristics are summarized in Table 1 and in
Supplementary Table 1.Table 1. Characteristics of screened patients, globally and according to
Characteristic All patients
(n ¼ 1,000)
No A
(n ¼
Age (y), mean  SD 64.0  11.6 63.8
Age  65 490 (49%) 462 (
Male gender 699 (69.9%) 658 (
Family history 79 (7.9%) 73 (7
Smoker ever 703 (70.3%) 666 (
Past smoker 434 (43.4%) 414 (
Current smoker 269 (26.9%) 252 (
Coronary proﬁle
No signiﬁcant lesion 267 (26.7%) 263 (
One-vessel disease 361 (36.1%) 350 (
Two-vessel disease 238 (23.8%) 228 (
Three-vessel disease 134 (13.4%) 117 (
Mean number of affected
coronary arteries  SD
1.2  1.0 1.2 
Aortic diameter (mm), mean  SDa 18.10  6.02 17.30
Note. Data are presented as mean  SD, number of patients (n), or p
a After exclusion of the 10 patients with previous AAA repair.US examination
AAA was diagnosed by ultrasonographic examination of the
abdomen using a 2.0e5.5 MHz convex-array probe (Logiq e
BT08 US sonographer; General Electric Healthcare, Little
Chalfont, UK). All examinations were done in B mode by the
same vascular operator the morning before coronary angi-
ography. The maximum infrarenal aortic diameter (ante-
roposterior or transverse axis) was obtained in the cross-
sectional view. Final diagnosis of AAA was based on an
anteroposterior and/or transverse diameter (outer-to-outer
diameter) measurement of 30 mm.
Statistical analysis
Quantitative variables were expressed as mean  SD,
whereas frequency tables were used for categorical ﬁnd-
ings. Student t test and chi-square test were used in uni-
variate analysis as appropriate. Logistic regression analysis
was applied to identify signiﬁcant AAA risk factors, sepa-
rately and in combination. Results were considered statis-
tically signiﬁcant at p < .05. All statistical tests were
performed using SAS package (version 9.3 for Windows).
RESULTS
During the screening period, 10 patients reported a history
of AAA repair, 13 others were already known to suffer AAA,
and 19 patients were newly diagnosed with AAA, thus
yielding a prevalence of 4.2% (n ¼ 42). The prevalence
amounted to 5.9% (41/699) in men and 0.3% (1/301) in
women. The characteristics of patients with and without
AAA are displayed in Table 1 for the most relevant variables
and in Supplementary Table 1 for the other variables. As
shown in Table 1, age 65 years (odds ratio [OR] ¼ 3.53;
95% conﬁdence interval [CI]: 1.54e8.09), male gender
(OR ¼ 19.3; 95% CI: 2.49e149), family history of AAA
(OR ¼ 3.80; 95% CI: 1.37e10.5), current smoking
(OR ¼ 5.93; 95% CI ¼ 1.85e19.1), and presence of a three-
vessel coronary disease (OR ¼ 10.5; 95% CI: 2.72e40.1)absence or presence of abdominal aortic aneurysm (AAA).
AA
958)
AAA
(n ¼ 42)
Univariate
analysis
Multivariate
analysis
 11.6 70.3  8.94 <.001
48.2%) 28 (66.7%) .007 .003
68.7%) 41 (97.6%) .004 .005
.6%) 6 (14.3%) .12 .01
69.5%) 37 (88.1%) .03 .005
43.2%) 20 (47.6%) .22
26.3%) 17 (40.5%) .003
<.0001 <.0001
27.5%) 4 (9.5%)
36.5%) 11 (26.2%) .47
23.8%) 10 (23.8%) .18
12.2%) 17 (40.5%) <.001
1.0 2  1 <.0001
 3.50 41.9  13.2 d d
ercentages.
Figure 1. Prevalence of abdominal aortic aneurysm (AAA) ac-
cording to age in men. Note. n ¼ number of patients with AAA;
N ¼ total number of patients in the subgroup.
Table 2. Distribution of known and discovered abdominal aortic
aneurysms (AAA) according to size and age.
AAA maximum
diameter (mm)
Number of patients
Discovered AAA
(n ¼ 19)
Known AAA
(n ¼ 13)
<65 y 65 y <65 y 65 y
<40 6 10 3 2
40 and <55 0 1 2 2
55 0 2 1 3
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AAA prevalence is displayed according to age in men in
Fig. 1, and according to coronary proﬁle and age in men in
Fig. 2.
The distribution of known (n ¼ 13) and newly diagnosed
(n ¼ 19) AAAs according to size and age is shown in Table 2.
When considering only the 19 cases of aneurysm previously
unknown and discovered by the screening, 16 (84.2%) had a
maximum diameter between 30 and 40 mm, while two
(10.5%) had a maximum diameter 55 mm and were
therefore treated surgically. Fig. 3 summarizes the preva-
lence of these newly detected AAAs according to coronary
proﬁle and age in men.
DISCUSSION
The association between AAA and atherosclerosis has been
known for a long time. Although some studies12,22e24 have
indicated that aneurysms arise through pathogenic mech-
anisms that differ, at least in part, from those responsible
for atherosclerosis, AAA and CAD share many risk factors. In
fact AAA prevalence was reported to be higher in patients
with CAD (Table 3),13e17 but all these studies included only
patients with severe CAD requiring coronary artery bypass
grafting or patients admitted with unstable angina. In the
present study, we prospectively analyzed a large cohort ofFigure 2. Prevalence of abdominal aortic aneurysm (AAApatients with a broader spectrum of CAD severity, the
objective being to examine the correlation between CAD
severity and AAA prevalence. CAD severity was intermedi-
ate in our population, as evidenced by the presence of a
signiﬁcant stenosis in, on average, 1.2 coronary vessels.
The prevalence of AAA in men aged 65 was reported to
range between 4.0% and 7.7% in several screening pro-
grams in northern Europe during the 1990s.8,9,25,26 In
contrast, the AAA prevalence in our study population was
surprisingly low (4.2%), despite the high risk character of
the selected population, but in which we also incorporated
patients <65 years and women.
By comparison, if we consider only the group of men
aged 65 years, the prevalence of AAA was 8.6%dmore
than twice that of the general population. However, this
prevalence is still lower than previously reported ﬁgures for
comparable patient populations, as listed in Table 3.13e17
This is consistent with several recent studies that indicate
a decrease of AAA incidence in the general population.
Svensjö et al.19 recently published a low prevalence of AAA
(2.2%) in a Swedish population of men aged 65 years,
suggesting a change in the epidemiology of the disease.
Anjum and Powell20 also observed a decline in the inci-
dence of clinically-relevant AAA in men in England, Wales,
and Scotland. At the same time, Norman et al.21 noted a fall
in the rates of discharge from hospital and mortality from
AAA in Australia since 1999. Interestingly, during an AAA
screening program performed on high-risk patients in the
early 1990s in our hospital, the prevalence of AAA in men
aged 60 years admitted for coronary artery bypass graft) according to the coronary proﬁle and age in men.
Figure 3. Prevalence of newly detected abdominal aortic aneurysm (AAA) according to the coronary proﬁle and age in men.
276 R. Durieux et al.was found to be 15%.18 In comparison, in this study, AAA
prevalence for the same subgroup of patients (8.1%) was
just above half of that estimated 20 years ago. This ﬁnding
also suggests a decrease in AAA prevalence.
As mentioned, the association between AAA and CAD has
been shown in several studies, and may be explained by the
fact that the two diseases share several risk factors.13e17
Here, CAD emerged as an independent risk factor for AAA
in multivariate analysis (p < .0001), but the association with
AAA was only statistically signiﬁcant for the three-vessel
disease subgroup (p < .001, OR ¼ 10.5; 95% CI: 2.72e
40.1). This is the ﬁrst study that clearly correlates AAA
prevalence with CAD severity, and identiﬁes three-vessel
disease as an independent risk factor for AAA. The associ-
ation between AAA and three-vessel disease was found to
be independent of traditional risk factors, suggesting a
speciﬁc relationship between the two disorders and a po-
tential beneﬁt for optimized screening targeting the sub-
group of patients with three-vessel CAD, regardless of age.
We should be careful, however, because a high AAA prev-
alence in a high-risk population does not imply that the
screening will be effective. Indeed, patients with three-
vessel CAD have a lower life expectancy and an increased
operative risk, which can reduce the costebeneﬁt ratio and
even the beneﬁt of the screening. Further research is
needed to clarify these aspects.
PAD was not associated with a higher risk of developing
AAA in our study, although Alund et al.27 reported anTable 3. Frequency of abdominal aortic aneurysms (AAA) in patients w
Study Year Number of
patients
P
Bergersen et al.15 1998 192 M
Dupont et al.13 2010 217 M
Long et al.14 2010 306 M
Madaric et al.16 2005 109 M
Monney et al.17 2003 395 M
This study 2010 1000 M
S
Note. CABG ¼ coronary artery bypass graft surgery.independent association between AAA and duplex-veriﬁed
arterial stenosis in an AAA screening study among patients
referred to the vascular laboratory for PAD.27 In this se-
lective screening study of a large cohort of patients
(nearly 6,000 participants) at high risk for PAD, the au-
thors showed that male gender, older age, and the pres-
ence of arterial stenosis were signiﬁcantly and
independently associated with AAA. In our study, the
diagnosis of PAD was based on clinical examination or
review of the medical chart, but not all patients under-
went an ultrasonic peripheral vascular examination, and it
is possible, therefore, that the frequency of PAD was
underestimated in our population, explaining the lack of
association between PAD and AAA. Similar to our study,
the screened population included men and women of all
ages. The AAA prevalence was reported to be 4.2% for
men (compared with 5.9% in our study) and 7.6% for men
aged 65 years with a duplex-veriﬁed peripheral stenosis
(compared to 16.4% for patients aged 65 years with
three-vessel CAD in our study). On this basis, the presence
of three-vessel CAD appears to be more discriminating
than the presence of PAD in determining a high-risk
population for AAA.
As previously reported in many studies, we found a
strong correlation between AAA prevalence and smoking,
male gender, older age, and family history of AAA in
multivariate analysis.21,28 These ﬁndings are well known,
but are still of interest in a contemporary cohort.ith coronary artery disease (CAD).
opulation Frequency of
AAA (%)
en and women, >50 y, CABG 18.2
en, 65 y, CAD 9.5
en, >50 y, CAD 9
en, >60 y, CAD 14
en, >60 y, CABG 10
en and women, coronary angiography 4.2
ubgroup of men aged 65 years 8.6
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of developing AAA, but the underlying mechanisms of this
protective role remain uncertain.29 In our study, we
observed a lower AAA prevalence in patients with type 2
diabetes compared with others (2.4% vs. 4.7%), but the
difference did not reach statistical signiﬁcance (p ¼ .09).
In more than half of patients with AAA (23/42), the
diagnosis was known before inclusion (10 patients were
operated on and 13 patients had a previously diagnosed
AAA). The majority of patients included in this study had
previous cardiac history and were followed up in outpatient
cardiology clinics. Cardiologists in our region are aware of a
high prevalence of AAA among patients with cardiovascular
risk factors. Therefore, many of them tend to attend a
routine assessment of the abdominal aorta during trans-
thoracic echocardiography (TTE). Previous studies have
shown that a rapid routine screening of abdominal aorta
during TTE is feasible using the same probe as for cardiac
examination (one cardiovascular shot) in more than 90% of
patients, and is accurate in comparison to that of a vascular
medicine specialist.30e34 Moreover, it requires little time
with an additional examination duration ranging from 1.7 to
4.4 minutes.30,33,34
It is noteworthy that approximately 90% of the newly
detected AAAs in our screening program had a diameter
<55 mm. Only 10.5% (2/19) of the AAA discovered by
screening had a maximum diameter >55 mm. This means
that most discovered AAAs are small in size and should be
subject to regular surveillance.
In summary, in our selected population, the prevalence of
AAA was particularly high in men aged 65 (8.6%) and also
in those with three-vessel CAD (12.7%), regardless of age
and other cardiovascular risk factors. Thus, we suggest a
rapid ultrasound examination of the abdominal aorta during
routine TTE for both speciﬁc groups. We realize, however,
that further clinical research studies, including long-term
follow-up and costebeneﬁt evaluations, are needed to
provide more and solid evidence for this recommendation
in general medical practice.
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